Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance

NCT04062890 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT04062890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04062890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance
Lead sponsor
University of Arizona
Phase
Phase 2
Overall status
Withdrawn
Start date
April 15, 2030
Completion date
December 30, 2030
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

glucose intolerance, hyperinsulinism, hypertension, insulin resistance, insulin sensitivity